ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — Cash Flow Quality Index
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Cash Flow Quality Index of 1.41x as of June 2024. Operating cash flow of €6.22 Billion exceeds net income of €4.40 Billion, indicating high earnings quality where cash backs reported profits. Also explore ASPEN PHAR.UN.ADR /1 O.N. balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ASPEN PHAR.UN.ADR /1 O.N. Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for ASPEN PHAR.UN.ADR /1 O.N. across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ASPEN PHAR.UN.ADR /1 O.N. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ASPEN PHAR.UN.ADR /1 O.N. (2022–2024)
Year-by-year earnings quality comparison for ASPEN PHAR.UN.ADR /1 O.N.. For live market cap and the full company financial profile, see LDZU company net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.41x | €6.22 Billion | €4.40 Billion | ▲ +33.9% |
| 2023 | 1.06x | €5.52 Billion | €5.23 Billion | ▲ +27.5% |
| 2022 | 0.83x | €5.37 Billion | €6.49 Billion | — |